| Literature DB >> 35521229 |
Yuanlan Ning1, Wen Shen1, Fen Ao1.
Abstract
The fiber obtained by electrospinning technology is a kind of biomaterial with excellent properties, which not only has a unique micro-nanostructure that gives it a large specific surface area and porosity, but also has satisfactory biocompatibility and degradability (if the spinning material used is a degradable polymer). These biomaterials provide a suitable place for cell attachment and proliferation, and can also achieve immobilization. On the other hand, its large porosity and three-dimensional spatial structure show unique blocking properties in drug delivery applications in order to achieve the purpose of slow release or even controlled release. The immobilization effect or blocking effect of these materials is mainly reflected in the hollow or core-shell structure. The purpose of this paper is to understand the application of the electrospun fiber based on biodegradable polymers (aliphatic polyesters) in the biomedical field, especially the immobilization or blocking effect of the electrospun fiber membrane on cells, drugs or enzymes. This paper focuses on the performance of these materials in tissue engineering, wound dressing, drug delivery system, and enzyme immobilization technology. Finally, based on the existing research basis of the electrospun fiber in the biomedical field, a potential research direction in the future is put forward, and few suggestions are also given for the technical problems that urgently need to be solved. This journal is © The Royal Society of Chemistry.Entities:
Year: 2020 PMID: 35521229 PMCID: PMC9057162 DOI: 10.1039/d0ra06865a
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Growth of Acetobacter xylem cells on nanofibers.
Fig. 2The chemical structure of some polyester materials.
Synthetic materials commonly used in electrospinning, and the expected uses of the prepared biological materials in tissue engineering
| Synthetic materials and additives | Spinning methods | Scaffold diameter | Cells for research | Intended use | Reference |
|---|---|---|---|---|---|
| PLLA | Single polymer solution spinning, uniaxial | 0.65 ± 0.03 μm | Decellularized corneal matrix | Corneal tissue engineering |
|
| PU | Single polymer solution spinning, uniaxial | 0.6–7 μm | mESCDCs | Cardiomyocytes for cardiac tissue engineering |
|
| PLA/EU | Single polymer solution spinning, uniaxial | — | Neuronal-like cell line (SH-SY5Y cells) | Neurodegenerative applications |
|
| PU/lecithin | Mixed solution spinning, uniaxial | 146.9 ± 33.7 nm | Hepatocyte |
|
|
| PLA/CS/calcium silicate | Mixed solution spinning, uniaxial | — | hMSCs | Bone tissue engineering |
|
| PLLA/SFA/SF | Mixed solution spinning, uniaxial | 0.77 ± 0.16 μm | Chondrocytes | Cartilage tissue engineering |
|
| PLLA/collagen/CS | Mixed solution spinning, stainless-steel rod collector | 89.33–246.7 nm | Lymphocyte T cell | Vascular graft tube |
|
| PLCL/collagen/CS | Mixed solution spinning, coaxial | 517 ± 112 nm | Porcine iliac artery endothelial cells (PIECs) | Vascular graft tube |
|
| PVA/PLA | Mixed solution spinning, coaxial | 149 ± 16.9 nm | MC3T3-E1 subclone 4 strain cells | Recovery of alveolar bone tissue |
|
| PLA/hydrosoluble collagen | Pattern template, Electrospinning | Around 200 nm | L929 cells | Scaffold, biosensor, or biofilter in tissue engineering |
|
| PLA/tussah silk fibroin (TSF) | Mixed solution spinning, uniaxial | 500 nm | Mouse mesenchymal stem cells (MSCs) | Repair structural bone |
|
| PLGA/poly( | Mixed solution spinning, uniaxial | 2.5 ± 0.2 μm | Human embryonic kidney (HEK) 293T cells | Guided tissue regeneration |
|
| PLA/GO- | Mixed solution spinning, uniaxial | 593 ± 98 nm | Swiss mouse NIH 3T3 ECACC cells | Tissue engineering |
|
| PCL/PGC | Mixed solution spinning, uniaxial | — | Endothelial progenitor cells | Vascularization; bone regeneration |
|
Mechanical properties of electrospun films with different morphologies.[51] Copyright 2018, Elsevier
| Groups | Breaking stress (MPa) | Breaking strain (%) | Young's modulus (MPa) |
|---|---|---|---|
| PDLA random | 3.9 ± 0.4 | 11.8 ± 3.0 | 302 ± 27 |
| PLLA random | 4.1 ± 0.3 | 13.2 ± 1.1 | 314 ± 30 |
| sc-PLA random | 4.8 ± 0.8 | 23.7 ± 2.8 | 331 ± 51 |
| sc-PLA/5% collagen random | 5.4 ± 0.4 | 18.0 ± 2.2 | 397 ± 29 |
| sc-PLA/10% collagen random | 5.7 ± 0.6 | 19.5 ± 3.7 | 446 ± 43 |
| sc-PLA/15% collagen random | 8.1 ± 0.7 | 15.1 ± 2.9 | 475 ± 35 |
Fig. 3Tubular materials similar to the shape of blood vessels.
Fig. 4(a) Schematic diagram of the process of preparing a nanofiber membrane by electrospinning, and applying it to a wound dressing. (b) Nanofiber membrane is applied to the wound.
Electrospun fibers loaded with drugs or active components, and their antibacterial properties
| Polymer | Antimicrobial agents or other antibacterial substances | Nozzle type | Antibacterial properties | Cell models and cytotoxicity | Reference |
|---|---|---|---|---|---|
| PCL/CA/PEO | CS | Double nozzle | — | L929 mouse fibroblast cells; no cytotoxicity |
|
| Eudragit® S100 (ES100) | Nitrofurazone | Single or coaxial nozzles |
| — |
|
| PU–Mt | Tetracycline hydrochloride | Single nozzle |
| Human fibroblast cell; apoptosis occurs when the drug concentration is high |
|
| PLA/MβCD | Quercetin | Single nozzle |
| — |
|
| PLA | Essential oils (EOs) of clary sage and black pepper | Single nozzle |
| — |
|
| PLLA | Bovine lactoferrin (bLF) | Single nozzle |
| Human skin fibroblasts (BJ-5ta cell line); no obvious cytotoxicity |
|
| PLA | Siliceous sponge spicules (SSS) | Single nozzle |
| CCD966SK cell; good cell compatibility |
|
| PLA/HBTC/im | Ag ions | Single nozzle |
| — |
|
| PLA | Colloidal nanosilver | Single nozzle |
| L929 cells; it shows a toxic effect with increased silver concentration |
|
| PVA/PVP/PEC/MF | Silver nanoparticles (AgNPs) | Single nozzle |
| HSF-PI 18 fibroblast cells; no obvious cytotoxicity |
|
| PCL/CS | Silver nanoparticles (AgNPs) | Coaxial nozzles |
| — |
|
Structure and release behavior of electrospun fibers loaded with some drugs
| Polymer | Fiber structure | Spinning type | Loaded drug | Drug release study | Bacteriostatic activity/cytotoxicity | Reference |
|---|---|---|---|---|---|---|
| PCL | Single and binary ketoprofen-loaded mats of ultrathin fibers | Ordinary solution spinning and emulsion spinning | Ketoprofen | Single mats exhibited burst release/binary mats exhibited sustained release | No sign of cytotoxicity |
|
| PLA | Core/shell structure | Emulsion spinning | Vancomycin hydrochloride | Sudden release in the initial stage (about 10% in 5 hours) and then slow release |
|
|
| PLA/collagen | Core/shell structure | Coaxial and uniaxial electrospinning | Gentamicin | The early release rate is fast, and there is a certain degree of retention behavior before reaching equilibrium |
|
|
| PMMA/PCL | Core/shell structure | Coaxial electrospinning | Nimesulide | The release of the drug in the shell is faster and more complete (almost 50% over 20 h), and the release of the drug in the core is slow (cumulative release 20% over 20 h) | — |
|
| GMS/EC | Core/shell structure | Modified coaxial electrospinning | Berberine hydrochloride | Showed good slow release performance (about 90% of 20 h release) | — |
|
| PLA/cellulose acetate | Core/shell structure | Coaxial wet-electrospinning | Citalopram | — | Have a positive effect on cell viability |
|
| PCL | Core/shell structure | Coaxial wet-electrospinning | BSA | Sudden release at the initial stage, followed by slow release, and the release rate decreased with the increase of PCL content | No cytotoxicity and good biocompatibility |
|
| Gliadin/cellulose acetate | Core/shell structure | Tri-axial electrospinning | Ibuprofen | Extended release duration and eliminated initial burst release | — |
|
| PLGA/PVP | Core/shell structure | Coaxial electrospinning | Metronidazole/naringin | The sudden release of MNA was more than 60% in the first hour, and the initial release of NAR was slow |
|
|
| PLLA | Core/shell structure | Emulsion spinning | Domiphen® | The sudden release of the drug was less, and entered the stage of drug release on the platform within 48 h | — |
|
| PCL | Hollow magnetic fibers | One-step coaxial electrospinning | Ketoconazole/Fe3O4 NPs | Rapid release within the first 0.5 h, followed by sustained release within 360 h | Has potential cytotoxicity |
|
Fig. 5SEM and TEM images of double drug-loaded nanofibers with core–sheath structure.[102] Copyright 2018, Elsevier.
Fig. 6The enzyme immobilization methods.[120] Copyright 2020, Elsevier.
Enzyme immobilized on a nanofiber mat and enzyme activity
| Nanofibers | Immobilized enzymes | Type of immobilization method | Enzyme activity | Reference |
|---|---|---|---|---|
| PMMA/PANI | Laccase | Adsorption and covalent binding | Retained over 80% relative activity after 30 days of storage and after 10 consecutive catalytic cycles |
|
| PAN/gold salt | Laccase | Adsorption | The enzyme activity after 7 days was 62.7% of that on the first day |
|
| PS | α-Chymotrypsin | Covalent binding | The activity of the immobilized enzyme was 65% of that of the free enzyme, and showed high activity in both aqueous and organic media |
|
| PVA | Cellulase | Covalent binding | The activity of the immobilized enzyme was more than 65% of that of the free enzyme, and the initial activity remained 36% after being reused 6 times |
|
| PVA | Cyclodextrin glucanotransferase | Covalent binding | Compared with the ordinary film, the enzyme activity immobilized on the nanofiber increased by 31% |
|
| P(GMA- | Lipase | Covalent binding | The maximum activity of 0.673 U mg−1 |
|
| P(GMA- | Lipase | Covalent binding | The residual relative activity of the immobilized lipase was 62% after 7 reuses |
|
| PVA/BSA | Horseradish peroxidase | Covalent binding | The residual activity of the immobilized HRP were 73% after 11 reuse cycles |
|
| PVA/CS | β-Galactosidase | Add the enzyme directly to the solution | The catalytic activity of enzyme-NF was 57.03% of free enzyme activity at pH 6.8 and 4 °C |
|
| CNTs-COOH/GO | Lysozyme | Covalent binding | The enzyme was considerably active |
|
| PANCMA | Lipase | Covalent binding | The enzyme loading and the activity retention of the immobilized lipase on the nanofibrous membrane increase from 2.36 ± 0.06 to 21.2 ± 0.7 mg g−1 and from 33.9 to 37.6%, respectively |
|
| PS/PSMA | Bovine carbonic anhydrase | Covalent binding, precipitation, and cross-linking | The enzyme maintained 65.3% of its initial activity after being incubated in aqueous solution at room temperature under shaking at 200 rpm for 868 days |
|
Fig. 7Schematic diagram of the preparation process of lipase immobilized on electrospun nanofibers.[131] Copyright 2018, Elsevier.
Fig. 8Effects of different parameters (voltage, flow velocity) on the fiber diameter.[133] Copyright 2018, Elsevier. (A) 20 kV, 0.5 ml h−1; (B) 20 kV, 0.1 ml h−1; (C) 30 kV, 0.5 ml h−1; (D) 30 kV, 0.1 ml h−1.
Effect of modification methods of electrospun polymer nanofibers on the detection effect of biosensors
| Electrospun polymer fibers | Modification method | Detection object | Test effect | Reference |
|---|---|---|---|---|
| PVA/PAMAM–Mt | Modification of Mt by PAMAMG2 | Glucose in beverages | The recovery rate is 100.45% |
|
| Polyaniline and polystyrene | Electrostatic layer-by-layer adsorption technique | Cholesterol | Accurate data can be obtained by depositing five cycles of COX on nanofibers |
|
| Gold nanoparticles (Au NPs)-crosslinked zein ultrafine fibers (CZUF) | Adding gold nanoparticles; combining electrospinning and one-step reduction method | Catechol | The interference is very small, and the sensitivity is very high |
|
| Cu-nanoflower@AuNPs–GO | Blending of GO and PVA | Glucose in biological fluids | The detection limit is 0.018 mM. The linear range is 1 × 10−6 to 1 × 10−4 M |
|
| CS–PVA | Add natural biopolymers | Glucose | The detection limit is 0.361 mM, and the linear range is 3.30 × 10−6 M to 5.56 × 10−2 M |
|